Traws Pharma, Inc. 8-K

What Happened

• Traws Pharma, Inc. (TRAW) announced via Form 8‑K that its stockholders approved a first amendment to the company’s 2021 Incentive Compensation Plan. The amendment increases the number of common shares available for issuance under the Plan by 2,000,000 and implements certain administrative changes. The amendment became effective on July 8, 2026 following the stockholder vote.

Key Details

• Item: Submission of Matters to a Vote of Security Holders (8‑K Item 5.07).
• Plan affected: Traws Pharma, Inc. 2021 Incentive Compensation Plan (amended).
• Share increase: 2,000,000 additional shares of common stock authorized for issuance.
• Effective date: July 8, 2026, upon receipt of stockholder approval.
• Related filing: Additional information appears in the company’s Definitive Proxy Statement on Schedule 14A filed May 29, 2026; the Amendment is attached as Exhibit 10.1 to the 8‑K.

Why It Matters

• Increasing the equity pool gives the company more shares to grant to employees, executives and directors as stock awards or options, which can be used for hiring, retention and incentive programs.
• For investors, this dilutes existing shares if awards are issued, so the change can affect share count and per‑share metrics over time; the 8‑K does not disclose immediate grants or dollar amounts tied to the amendment.
• The filing documents and the attached amendment (Exhibit 10.1) provide the definitive terms for the change and are the place to check for specifics on grant limits, vesting or other administrative provisions.